TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer
Clinical trial NCT07044908 · RECRUITING
Trial details
- NCT number
- NCT07044908
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2026-07-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.